1 Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM. Application of
Framingham risk estimates to ethnic minorities in the UK and
implications for primary prevention in general practice: a cross
sectional population based study. BMJ 2002;325:1271-4.
2 BrindleP,MayM,GillP,CappuccioFP,D’AgostinoRSr, FischbacherC,
et al. Primary prevention of cardiovascular disease: a web-based risk
score for seven British black and minority ethnic groups. Heart
2006;92:1595-602.
3 LittleP,Kelly J,Barnett J,DorwardM,MargettsB,WarmD.Randomised
controlled factorial trialofdietaryadvicefor patientswithasinglehigh
blood pressure reading in primary care. BMJ 2004;328:1054-7.
4 World Health Organization. Reducing salt intake in populations:
report of a WHO forum and technical meeting. Geneva: WHO,
2007:1-60.
5 Cappuccio FP. Salt and cardiovascular disease. BMJ
2007;334:859-60.
6 Sever PS,Dahlöf B, Poulter NR,Wedel H, Beevers G, Caulfield M, et al.
Prevention of coronary and stroke events with atorvastatin in
hypertensive patients who have average or lower-than-average
cholesterol concentrations, in the Anglo-Scandinavian Cardiac
Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre
randomized controlled trial. Lancet 2003;361:1149-58.
7 British Cardiac Society, British Hypertension Society, Diabetes UK,
HEART UK, Primary Care Cardiovascular Society, Stroke Association.
JBS 2: Joint British Societies’ guidelines on prevention of
cardiovascular disease in clinical practice. Heart
2005;91(suppl 5):v1-52.
8 WilliamsB, PoulterNR,BrownMJ, DavisM,McInnes GT,Potter JF, et al.
Guidelines for management of hypertension: report of the fourth
working party of theBritish HypertensionSociety, 2004-BHSIV.JHum
Hypertens 2004;18:139-85.